We introduced and optimized a novel sequence of fast (about 4 min), volumetric, high resolution, simultaneous bright-and black-blood imaging with sufficient T 1 contrast between enhanced metastasis and surrounding brain parenchyma for their differentiation. This proposed sequence can be used for 3-dimensional volumetric T 1 -weighted bright-and black-blood imaging in contrast-enhanced studies and may be promising for detecting small brain metastases by improving differentiation between blood vessels and small brain metastases.
Introduction
Contrast-enhanced (CE) magnetic resonance (MR) imaging is a promising modality for screening brain metastasis. 1 On T 1 -weighted images, paramagnetic contrast agents exhibit metastatic lesions as hyperintensities. An aggressive method is needed to detect brain metastases smaller than 10 mm because of the significantly higher rate of local control of small lesions of the brain by radiosurgery. 2 Contrast-enhanced 3-dimensional (3D) T 1 -weighted imaging based on gradient recalled echo (GRE) is widely used to detect small brain metastases 3, 4 but may not allow easy differentiation of (enhanced) vessels and tumor because contrast materials remain in both blood and the tumor parenchyma. 4 To solve this problem, black-blood versions of T 1 -weighted images based on turbo spin echo (TSE) applied with the so-called motion-sensitized driven equilibrium (MSDE) pre-pulse have recently come into use. 5, 6 The MSDE pre-pulse comprises a series of radiofrequency (RF) pulses with 90°/ 180°/¹90°flip angles (i.e., T 2 -prep pulse) and motion-sensitization gradients that are placed symmetrically around the 180°pulse. 7 Similar to the motion-probing gradients on single-shot echoplanar imaging (EPI)-based diffusion-weighted images that can effectively suppress the signal of (flowing) vessels, this pair of gradients at MSDE can also suppress vessels. Nevertheless, the sometimes imperfect vessel suppression can make differentiation between residual blood vessels and small brain metastases difficult. Nagao and associates 6 have described improved differentiation using a combination of MSDE-TSE (black-blood images) and GRE (bright-blood images) in their study with doubledose (0.2 mmol/kg) administration of gadoteridol. GRE images permit continuous visualization of vessels over imaging slices to provide confident differentiation of vessels from metastasis. 6 Consequently, their combined use with MSDE-TSE allows high diagnostic performance while maintaining a low false-positive rate. However, realistically, the 2 techniques cannot be combined because of the prolonged acquisition time. In fact, a recent publi- cation reports that it takes around 12 min for both scans and is difficult to set for routine clinical sequence. Therefore, a high speed sequence that permits simultaneous acquisition of both bright-and black-blood images is needed clinically. We propose a new scheme of fast, volumetric, high resolution, and simultaneous bright-and black-blood imaging-volume isotropic simultaneous interleaved bright-and black-blood examination (VISIBLE)-based on a 3D multi-phase GRE sequence. VISIBLE is intended to improve differentiation of small metastases from small vessels by comparing black-blood (vessels suppressed as much as possible) and bright-blood (vessels intentionally visualized as much as possible) imaging obtained simultaneously. We hypothesized that we could use the VISIBLE examination to obtain similar characteristics in a shorter acquisition time to those reported by Nagao's group with their combination method. Therefore, we undertook this study to set optimal parameter values for this sequence and then compare the effect of vessel suppression between our black-blood/bright-blood images and those obtained with Nagao's method.
Materials and Methods

Sequence design
Like the conventional "bright-blood" 3D GRE sequence, the VISIBLE sequence was based on a 3D T 1 -turbo field echo (T 1 TFE) sequence with centric phase encoding. This sequence has the potential to employ the black-blood pre-pulse called improved MSDE (iMSDE). 8 When performed with the iMSDE, T 1 TFE can provide black-blood images; without iMSDE, bright-blood images result. Balu and colleagues obtained high quality black-blood images in the carotid arteries using 3D MSDE-prepared rapid gradient echo (3D-MERGE), which is similar to T 1 TFE with iM-SDE. 9, 10 We attempted to use the multi-phase (2 phases) version of 3D MERGE for simultaneous acquisition of black-blood images at the first phase with centric phase encoding (with iMSDE), followed by bright-blood images at the second phase with reverse-centric phase encoding (with no more effect of iMSDE). Thus, we employed iMSDE only once before the initial phase. Shortening of the T 1 relaxation time of blood by the contrast agent can be expected to further increase the blood signals at the second phase. Figure 1 shows the sequence diagram of VISIBLE.
The original MSDE preparation consists of T 2 preparation (90°/180°/¹90°) pulses with motionsensitizing gradients sandwiched between the RF pulses. iMSDE has been developed to address the sensitivity of MSDE to eddy currents and the inhomogeneity of MSDE image quality. The iMSDE preparation consists of a 90°excitation pulse, two 180°Malcom-Levitt (MLEV) refocusing pulses, and a ¹90°flip-back pulse with motion-sensitizing gradients sandwiched between the RF pulses. Additional bipolar gradients inserted in front of the 90°excitation pulse work to compensate for eddy currents. 5 
Experiments
We examined 17 patients with or without brain metastasis using a 3.0-tesla whole-body clinical imager (Achieva TX, Philips Healthcare, Best, The Netherlands). Our local institutional review board approved the study, and we obtained written informed consent from all subjects. The diagnosis of brain metastasis was based on histologic analysis or follow-up MR findings interpreted by 2 experienced radiologists (S.S., S.T.) in consensus.
The study consisted of 3 parts-optimization of black-blood imaging, evaluation of the capacity of bright-blood imaging to show sufficient vessels, and direct comparison of the VISIBLE (black and bright images) and conventional combined (MSDE-TSE and magnetization-prepared rapid acquisition with gradient-echo [MPRAGE]) methods.
Optimization of black-blood imaging: We examined 10 patients with brain metastasis. As described above, it is important to suppress vessels that mimic (enhanced) metastasis for better differentiation and to guarantee good contrast between enhanced metastasis and surrounding brain parenchyma (i.e., adequate T 1 contrast) in black-blood images.
For the first requirement, Nagao's group evaluated the number of visualized vessels as an indicator of the black-blood effect, counting the visualized vessels (arteries and veins) in a single section through the level of the centrum semiovale. 6 We followed this method but used single-dose (0.1 mmol/ kg) administration of gadopentetate dimeglumine (Magnevist μ , Bayer Yakuhin, Osaka, Japan). For each parameter setting, one of the authors (M.Y., with more than 15 years of experience with MR imaging) visually counted blood vessels in a single section at the level of the centrum semiovale on the LCD monitor of a picture archiving and communication system (PACS, Extended MR WorkSpace, Philips Healthcare). Subsequently, another author, a board-certified radiologist (S.T.), carefully differentiated vessels and lesions and subtracted the number of lesions from the number of vessels previously counted. We used fewer than 10 vessels at the level of the centrum semiovale as the criterion for sufficient black-blood imaging because that was Nagao's findings. For the second requirement, we evaluated the contrast ratio (CR) between metastasis and surrounding parenchyma (CR WM-Tumor ) and between gray (GM) and white matter (WM) (CR WM-GM ) in the black-blood image as an indicator of T 1 contrast: in which SI is the signal intensity.
It is important that the parameters chosen for black-blood imaging do not result in the suppression of overall signal intensity in the brain. To confirm that the parameters we chose for black-blood Fig. 1 . Scheme of volume isotropic simultaneous interleaved bright-and blackblood examination (VISIBLE) sequence. (a) VISIBLE is based on a 2-phase version of improved motion-sensitized driven equilibrium (iMSDE)-prepared 3-dimensional (3D) T 1 -turbo field echo sequence (T 1 TFE) for the simultaneous acquisition of black-and bright-blood images. A set of iMSDE and 2 phases of 3D T 1 TFE make up the so-called TFE shot, which is one cycle of sequence, like repetition time (TR) in other pulse sequences. (b) The black-blood images are obtained by MSDE preparation at the first phase, and the bright-blood images are obtained by T 1 recovery of blood signals at the second phase. (c) Modified kspace order is utilized to obtain optimal blood signal at respective phases: (1) centric k-space order is applied to the first phase; (2) reversed-centric k-space order is applied to the second phase.
imaging would not adversely affect brain signals, we also measured the signal-to-noise ratio (SNR) in white matter (SNR WM ) in the black-blood image by dividing the WM signal in the region of interest (ROI) by the standard deviation (SD) of noise measured outside the brain: SNR WM ¼ SIðWMÞ=SD of noise ðoutside the brainÞ:
One of the authors (M.Y.), who was blinded to the type of image under evaluation, placed ROIs over the WM (measured in the genu of the corpus callosum), GM (measured in the head of the caudate nucleus), and tumor (selected lesion with a diameter >5 mm and homogeneous solid enhancement, excluding lesion edges to avoid a partial volume effect and defining the ROIs carefully to avoid the cerebrospinal fluid [CSF] or vessels). The diameter of each ROI was 5 mm. Placement of the ROIs and size of cursor were matched for the different image sets in a given patient. We conducted all qualitative and quantitative analyses in a blinded manner.
The flip angle and turbo factor play important roles in relation to black-blood effect and T 1 contrast. Generally, use of a large FA improves T 1 contrast but deteriorates the black-blood effect by increasing the inflow effect, which causes an increase in the signal of blood, and its use suppresses stationary spins in the surrounding brain parenchyma. Use of a large turbo factor improves T 1 contrast by permitting sufficient time for T 1 recovery for the next excitation, but its use deteriorates the blackblood effect because of an increase in the signal of blood during the long recovery time. Therefore, the values of FA and turbo factor should be well balanced to keep both adequate black-blood effect and T 1 contrast.
We examined imaging parameters: field of view (FOV), 240 mm; resolution, 1.0 mm 2 ; 60 slices; slice thickness, 3.0 mm; repetition time (TR), 7.5 ms; echo time (TE), 3.2 ms; FA, 10, 15, and 20°; turbo factor of 30, 60, 90, and 120; and total acquisition time, 40 s.
We assessed the numbers of visualized blood vessels, CR WM-GM , CR WM-Tumor , and SNR WM using one-way repeated-measures analysis of variance (ANOVA) and post hoc Tukey test because the data fit a normal distribution (Shapiro-Wilk normality test).
Evaluation of bright-blood imaging in the number of visualized vessels: Comparison to results in the literature: We examined 10 patients with brain metastasis. Bright-blood imaging aims to intentionally maximize visualization of (enhanced) vessels, allowing their continuous visualization over the slices so that we may confidently differentiate vessels (as continuous structures) from metastasis (as noncontinuous structures). To evaluate the quality of bright-blood images, Nagao's team counted the visualized vessels 6 and obtained 2 results at 2 different times after injection of contrast material-73 vessels at 5 min after injection and 50 vessels at 19 min after; the larger number at 5 min than 19 min represented the higher concentration of contrast material early after injection. We investigated whether our results approximated the 2 results of Nagao described. In our study, the scan was started at 5 min after contrast injection.
The imaging parameters for VISIBLE were: FOV, 240 mm; resolution, 1.0 mm 2 ; 180 slices; slice thickness, 1.0 mm; TR, 7.5 ms; TE, 3.2 ms; FA, 15°; turbo factor, 30; iMSDE preparation (duration, 15 ms, target flow velocity (VENC), 1.0 cm/s); and total acquisition time, 4 min (2 min/phase).
Direct comparison of VISIBLE (black and bright images) and conventional combined method (MSDE-TSE and MPRAGE):
To demonstrate the feasibility of the VISIBLE sequence (black-and bright-blood images), we compared it directly with the conventional method combining MSDE-TSE as black-blood images and MPRAGE as bright-blood images). We examined 7 patients (5 patients with no enhancing lesion, 2 patients with enhancing lesion). We evaluated the degree of blood vessel suppression (in black-blood images) or enhancement (in bright-blood images) by counting the visualized blood vessels in a single section at the level of the centrum semiovale in the 5 patients with no enhancing lesion (i.e., without metastasis). We also compared the lesion-to-normal contrast-to-noiseratio (CNR) 6 where SI (lesion) represents the mean signal intensity of the lesion and SI (background), the mean signal intensity of normal-appearing white matter in the same section, and SD (lesion) and SD (background) are the corresponding standard deviations. We did not analyze statistics in this experiment because results from only a few patients would not be very reliable. Table 1 shows the scanning parameters for each sequence. To minimize bias in estimating the signal intensity of the brain tumors and vessels, which may be caused by the difference in time lag be-tween contrast injection and imaging, we scanned 3 sequences in random order in all patients.
Results
Optimization of black-blood imaging
Flip angle: Table 2 shows the quantitative comparison of FA in relation to the numbers of visualized blood vessels as well as the CR WM-GM , CR WM-Tumor , and SNR WM . As the FA increased, the number of blood vessels, CR WM-GM , and CR WM-Tumor increased, but the SNR WM decreased. Consequently, we judged an FA of 15°to be good to obtain adequate T 1 contrast and effective suppression of blood signals in keeping a practical SNR.
Turbo factor: Table 3 shows the quantitative comparison of turbo factor in relation to the number of visualized blood vessels, CR WM-GM , CR WM-Tumor , and SNR WM . As the turbo factor increased, the number of blood vessels, CR WM-GM , and SNR WM increased, but the CR WM-Tumor decreased. Therefore, we judged a short turbo factor of 30 best to obtain high CE and suppression of blood signals.
Thus, we judged an FA of 15°and turbo factor of 30 to be the optimal parameters to meet the criteria for sufficient black-blood images and obtain the highest CR and SNR.
Evaluation of bright-blood imaging in the number of visualized vessels: Comparison to results in the literature: Table 4 shows the quantitative comparison of VISIBLE bright-blood images in comparison with Nagao's results. The number of visualized blood vessels by VISIBLE at 5 min after injection was 53 vessels, which was close to Nagao's findings of 50 vessels at 19 min after injection. The relative percentage of visualized vessels with VISIBLE at 5 min after injection compared with Nagao's results after 5 min was 73% and after 19 min, 105%.
Figures 2 and 3 are representative images with contrast-enhanced VISIBLE sequences of patients with brain metastasis. The total acquisition time was 4 min. In Fig. 2 , the VISIBLE black-blood image clearly shows brain metastases without disturbing blood vessel structures. Figure 3 explains that even a vessel with imperfect suppression is easily confirmed as a vessel by looking at the bright-blood images.
Direct comparison of VISIBLE (black-and bright-blood images) and conventional combined method (MSDE-TSE and MPRAGE): Table 5 shows the quantitative comparison of VISIBLE (blackand bright-blood images) and MSDE-TSE (blackblood images) and MPRAGE (bright-blood im- iMSDE, improved motion-sensitized driven equilibrium; MPRAGE, magnetization-prepared rapid acquisition with gradient echo; MSDE, motion-sensitized driven equilibrium; N/A, not applicable; SENSE, sensitivity encoding; TSE, turbo spin echo; VENC, velocity encoding; VISIBLE, volume isotropic simultaneous interleaved bright-and black-blood examination ages). The number of blood vessels was similar between VISIBLE black-blood images and MSDE-TSE and between VISIBLE bright-blood images and MPRAGE. The CNR was comparable between VISIBLE black-blood images and MSDE-TSE and superior in VISIBLE bright-blood images to that in MPRAGE.
Discussion
Theoretically, the VISIBLE sequence we propose allows a single acquisition of both black-and bright-blood images in only 4 min. If this technique is adequate to obtain both sides of the images effectively, its short acquisition time should be useful in clinical application. In the first part of our study, we confirmed the suitable parameters for black-blood images by balancing the number of nonsuppressed vessels (<10 vessels at the level of the centrum semiovale) and CR, and we found that the VISIBLE sequence could achieve satisfactory black-blood images with good T 1 contrast. With respect to acquisition of bright-blood imaging, we could visualize a comparable number of vessels to Nagao's results. 6 The results of number of vessels of VISIBLE were inferior to that of MPRAGE of 5 min after injection, but it was almost equivalent to that of MPRAGE at 19 min after injection. Because we used a single dose, only half the dose used in Nagao's trial, we believe our findings encourage the use of our technique with a single dose for daily clinical practice. We felt that the VISIBLE sequence permitted satisfactory black-and brightblood images, though the number of vessels in bright-blood images was slightly smaller (Figs. 2,  3) . In direct comparison with conventional combi- CR, contrast ratio; GM, gray matter; SNR, signal-to-noise ratio; WM, white matter *P < 0.01 compared with flip angle of 10°; **P < 0.01 compared with flip angle of 15°V alues are presented as means « standard deviation (SD). The turbo factor was held fixed at 30. CR, contrast ratio; GM, gray matter; SNR, signal-to-noise ratio; WM, white matter *P < 0.01 compared with turbo factor of 30; **P < 0.01 compared with turbo factor of 60; ***P < 0.01 compared with turbo factor of 90 Values are presented as means « standard deviation (SD). The flip angle was held fixed at 15°. CNR, contrast-to-noise ratio; MPRAGE, magnetization-prepared rapid acquisition with gradient echo; MSDE, motionsensitized driven equilibrium; TSE, turbo spin echo; VISIBLE, volume isotropic simultaneous interleaved bright-and black-blood examination Values are presented as means « standard deviation (SD).
CNR of the VISIBLE bright-blood image was superior to that of MPRAGE. Though we obtained our results from very few patients, we believe that the VISIBLE sequence offers sufficient enhanced lesion-to-parenchyma contrast that is comparable to that of MSDE-TSE. Because we obtained similar CNRs of MSDE-TSE and MPRAGE to those observed by Nagao (about 11 for CNR of MSDE-TSE, about 8 for CNR of MPRAGE), we considered our results of direct comparison to be sufficiently reliable.
The total imaging time of the VISIBLE sequence, approximately 4 to 5 min, is very practical for clinical use. It takes only 2 min to obtain one-millimeter isotropic T 1 -weighted black-blood images of the entire brain. This sequence is significantly faster than the previously reported TSE-or GRE-based whole-brain black-blood imaging 4 -6,11,12 and still permits sufficient T 1 contrast.
Our study has several limitations. First, we directly compared results of the VISIBLE sequence and conventional combination (MSDE-TSE, MPRAGE) in only a few patients because excessive acquisition times frequently caused unacceptable motion artifacts. Second, we do not know if the bright-blood effect seen on the images was sufficient for clinical use. Furthermore, the MSDE pre-pulse, which is a part of the VISIBLE sequence we studied, inherently causes SNR decrease and image inhomogeneity as a result of eddy current effect from motion-sensitized gradients. Therefore, further exploration with this technique in patients with brain metastases is needed to assess its clinical value.
Conclusion
This study showed a new scheme of fast (around 4 min), volumetric, high resolution, simultaneous bright-and black-blood imaging. This sequence can be used for 3D volumetric T 1 -weighted brightand black-blood imaging and may be promising for detecting small brain metastases because it improves differentiation between blood vessel and small brain metastases.
